Home/Filings/4/0001562180-24-004774
4//SEC Filing

Madden Martin J. 4

Accession 0001562180-24-004774

CIK 0001645113other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 6:13 PM ET

Size

7.8 KB

Accession

0001562180-24-004774

Insider Transaction Report

Form 4
Period: 2024-06-05
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-05+6,2296,229 total
    Exercise: $23.13Exp: 2034-06-04Ordinary Shares (6,229 underlying)
  • Award

    Ordinary Shares

    2024-06-05+4,05319,673 total
Footnotes (3)
  • [F1]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
  • [F2]Report no longer includes indirect ownership of shares held by filer's adult child. Child no longer shares a residence with the filer.
  • [F3]Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001696864

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:13 PM ET
Size
7.8 KB